GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study (REDUCE PAS)

    Not Recruiting
  • sponsor
    W.L.Gore & Associates
Updated on 2 August 2021


The GORE GSO 18-01 study is a Post Approval Study assessing the safety and effectiveness of the GORE Septal Occluder device as observed in the REDUCE pivotal IDE study, evaluating the quality of operator education and training and transferability of trial experience to a post-market setting.


  • Condition: Stroke, Patent Foramen Ovale 
  • Device: PFO closure with GORE® CARDIOFORM Septal Occluder
  • Clinical Trial Identifier: NCT03821129

Condition Occlusions, Stroke
Clinical Study IdentifierTX276527
SponsorW.L.Gore & Associates
Last Modified on2 August 2021

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note